CHARLOTTESVILLE, Va. (WSET) -- UVA Health will be launching a clinical trial to test the effectiveness of using plasma from recovered COVID-19 patients as a potential treatment for inpatients with the disease.
According to the university, inpatients at UVA that have tested positive for COVID-19 will be offered the opportunity to participate in the trial.
Plasma from recovered patients, also known as convalescent plasma, has antibodies to COVID-19 that potentially could aid in treatment, UVA Health officials say.
More on this story from our media partner, ABC 13 - WSET.